Internet platform opens appointments for domestic live attenuated herpes zoster vaccination
Recently, Changchun BacTech Biotechnology Co., Ltd. announced that the company recently received the Drug Registration Certificate for the live attenuated herpes zoster vaccine from the State Drug Administration. This means that the world’s first marketing application for a live attenuated herpes zoster vaccine for adults aged 40 years and above has been approved in mainland China.
On the 2nd, Ali Health launched a domestic herpes zoster vaccination demand registration service, which allows users aged 40 and above with vaccination needs to fill in information online and subscribe to vaccination reminders.
According to several media reports, before the product was approved, there were not many options for shingles vaccine in the market. Only two herpes zoster vaccines were approved for the global market, and only one of them was available in China. The approval of the vaccine on the market not only enriches the choice of users, but also relaxes the age of vaccination for shingles vaccine to 40 years.
Herpes zoster is an acute infectious skin disease caused by the reactivation of the varicella-zoster virus that is latent in the body. The complication of shingles postherpetic neuralgia (PHN) is painful and unbearable for the patient.
More Stories
New crown track into the red sea, Pfizer 100 billion revenue is also difficult to sustain
Despite the negative news about the new crown concept products, the increasing cost of innovation, the rise of companies in...
New crown vaccine “one shot a year” is still controversial, China to follow?
Recently, the U.S. Food and Drug Administration (FDA) released its "Updated Proposal to Simplify New Crown Vaccination," saying that in...
When can I get other vaccines after being infected with the new coronavirus? Anhui CDC issues vaccination tips before school starts
Do I need to pay attention to my child's vaccination status before school starts? Recently, due to the new coronavirus...
New crown vaccine sales revenue declined sharply year-on-year Conchino’s 2022 prep loss topped nearly 1 billion yuan
Conxino released a performance forecast in the evening of January 30, expecting that the net profit attributable to owners of...
Jiangxi CDC important reminder!
Why do children need vaccinations? Babies are born with maternal antibodies mainly from their mothers to fight diseases, but as...
Beijing reported a cumulative total of 64,507,800 doses of new coronavirus vaccine
As of January 27, 2023, a cumulative total of 64,507,800 doses of the new coronavirus vaccine were reported in Beijing,...
Average Rating